WORLDWIDE THERE ARE APPROXIMATELY

• 50 MILLION DIABETIC RETINOPATHY

• 2 MILLION RETINITIS PIGMENTOSA

patients where these progressive eye diseases can result in blindness. While these

progressive neurodegenerative diseases can be treated at varying degrees with

contemporary treatment methods, in some stages and cases they may be insufficient.

MagnoVision MG10 therapy device, used alone or in combination with other treatment

methods, can slow or stop blindness in appropriate cases.

This medical device has a helmet; that stimulates the retina and the visual pathways

without touching the eyeball by generating electromagnetic field and a control unit;

where the treatment parameters are set by the doctor and secured so that it cannot

be changed by the patient. High-frequency repetitive electromagnetic stimulation

(high-frequency rEMS) generated by the device is a safe and harmless method

because it is far below the specified safety limit.

Since the diseases mentioned above usually require a long-term treatment, the patient

can also use the MagnoVision MG10 therapy device at home after the treatment

parameters in the control unit are set and secured by the physician. Thepatient or their

relatives should contact the physician and / or technical service atrecommended

intervals or in case of need.